Increased therapeutic effect on medullary thyroid cancer using a combination of radiation and tyrosine kinase inhibitors

Since patients with medullary thyroid cancer (MTC) often have metastatic disease at the time of diagnosis, the development of efficient systemic treatment options for MTC is important. Vandetanib and cabozantinib are two tyrosine kinase inhibitors (TKIs) that were recently approved by FDA and EMA fo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:PLoS One
Autors principals: Sandblom, Viktor, Spetz, Johan, Shubbar, Emman, Montelius, Mikael, Ståhl, Ingun, Swanpalmer, John, Nilsson, Ola, Forssell-Aronsson, Eva
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2020
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7252631/
https://ncbi.nlm.nih.gov/pubmed/32459817
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0233720
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars